Newsletter | April 17, 2024

04.17.24 -- The Next Evolution In Immuno-Oncology

SPONSOR

Use of a high salt concentration during the cell lysis step in AAV production delivers higher titers and massively improves virus infectivity. However, high salt conditions inhibit activity of conventional endonucleases used for DNA digestion. Learn how our NEW GMP grade Benzonase® Salt Tolerant endonuclease enables incorporation of high salt concentrations during this midstream step.

FEATURED ARTICLES

Delivering The Next Evolution In Immuno-Oncology

To continue the momentum created by new discoveries and treatments for cancer patients, drug developers need a strong and focused corporate culture, employees willing to challenge established norms, and a system for prioritizing development candidates guided by science and patient needs.

INDUSTRY INSIGHTS

Leveraging Stable Pool Material To Expedite The Path To IND

Review the efficacy of fast stable pools in generating purified products at an early stage and learn how to accelerate the journey toward first-in-human trials and proof-of-concept studies.

The Importance Of Understanding Materials In Medical Product Development

Examine considerations for the series of characterizations necessary to ensure the efficacy of a packaging or device component and final drug delivery system.

Early Plasmid Optimization For Long-Term Commercial Success

Securing the right plasmid for an application can be a complex endeavor. Core to this is selecting a supplier with the quality assurance protocols and GMPs to facilitate optimized plasmid production.

Staying Ahead Of The Latest Developments And New Transparency Rules

Navigating the Clinical Trials Regulation (CTR) in the EU presents challenges amid evolving guidelines. Recent updates, like transparency rule changes, aim to streamline compliance.

Re-Imagining Chromatography: Building Efficient Downstream Processes

Explore a stepwise approach for integrating process intensification principles into an existing process to increase productivity, reduce costs, and improve process sustainability.

Optimizing Revenue For Clinical Trials

Tracking billing and expenditures with notepads and Excel spreadsheets isn’t enough to meet client needs or auditing regulations. Find a new software solution CROs are using to be more proficient.

Optimizing Formulations With Bioavailability Enhancement Technologies

API-sparing development techniques and identification of the appropriate scalable formulation technology to improve solubility and enhance oral bioavailability can increase your chances of success.

CONTRIBUTE TO LIFE SCIENCE LEADER

Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director. 

Connect With Life Science Leader: